Juliane Mills

Juliane Mills has an extensive work experience in the field of clinical trials and scientific research. Juliane is currently serving as the Senior Director and Therapeutics Strategy Lead at Worldwide Clinical Trials since August 2023. Prior to this, they worked as a Science Consultant at the Chan Zuckerberg Initiative from January 2022 to August 2023. Juliane has also held positions at ICON plc, PRA Health Sciences, United BioSource Corporation, Association of Women in Science, Covance, Centocor, Inc., DuPont Pharmaceuticals, and the Hospital of the University of Pennsylvania. Juliane'sroles in these organizations varied from senior director to project manager, research scientist to medical technologist. Juliane's expertise lies in rare diseases, scientific affairs, therapeutic expertise, and research management.

Juliane Mills holds a Master of Science degree in Public Health from Drexel University. Juliane also has a Master of Science degree in Scientific Communication from the same university. Juliane obtained their Bachelor of Science degree in Clinical Laboratory Science/Medical Technology from the University of Rhode Island. Additionally, they have studied Bioinformatics/Biotechnology at the University of Pennsylvania and Database Management at Widener University.